plozasiran
plozasiran is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including REDEMPLO. Available dosage form: injection, solution.
Drug Details
- Generic Name
- plozasiran
- Brand Names
- REDEMPLO
- Application Number
- NDA219947
- Sponsor
- Arrowhead Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- PLOZASIRAN
Indications and Usage
1 INDICATIONS AND USAGE REDEMPLO is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). REDEMPLO is an apolipoprotein C-III ( apoC-III )-directed small interfering ribonucleic acid (siRNA) indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). ( 1 )